Acquired metallo-β-lactamases (MBLs) belong to the families IMP, VIM, NDM, SPM, GIM, SIM, DIM, KHM, TMB, FIM, and AIM ([@R1]). IMP and VIM are the most common families. MBLs have been reported worldwide among *Pseudomonas aeruginosa* isolates ([@R2]). Therapeutic options for infected patients are severely limited because isolates are resistant to many classes of antimicrobial drugs. Genes for MBLs are found mostly in class 1 integrons, which carry additional drug resistance genes. To date, 33 of the 51 known IMP variants have been detected in *P. aeruginosa*; there has been only 1 report of an IMP-19 producer ([@R3]). This MBL is widespread among *Acinetobacter* spp. in Japan and has also been reported in *Achromobacter xylosoxidans* ([@R4]*,*[@R5]).

During 2009--2016, infections with IMP-19--producing *P. aeruginosa* isolates were detected in 7 patients in the Hematology Department of University Hospital François Mitterrand, a 1,600-bed hospital in Dijon, France. We describe these infections and report results of environmental investigations.

The Study
=========

The hematology department of the hospital contains a 15-bed conventional unit and a 9-bed protective isolation unit. At the entrances of rooms in the conventional unit, there is a hand hygiene sink (for staff and visitors) and a bathroom in a separate area (shower stall, sink, and toilets). In the protective isolation unit, air is filtered through a laminar flow system, and a sink and toilets are located next to each bed (distance 1.5 m). The ceramic sinks have no counter space, and drains are made of stainless steel. All faucets in the department are hand-operated and provided with antibacterial filters (0.22 μm). Surfaces are cleaned daily (once in the conventional unit) and twice in the protective isolation unit with a solution containing quaternary ammonium compounds (0.25% didecyldimethylammonium chloride).

During 2009--2016, a total of 7 patients (P1--P7) in the department were infected or colonized by IMP-19--producing *P. aeruginosa*, which were isolated from blood samples (2 patients), urine samples (2 patients), throat swab samples (2 patients), and a central venous catheter (1 patient). All patients underwent throat, urine, and feces sampling at admission and were free of *P. aeruginosa,* thus indicating nosocomial acquisition. All isolates were resistant to ceftazidime, imipenem, meropenem, doripenem, ciprofloxacin, and most aminoglycosides; 4 isolates were susceptible to piperacillin and 3 to amikacin.

We conducted an environmental investigation in the hospital ([Figure 1](#F1){ref-type="fig"}). More than 100 environmental samples were obtained when no patients were colonized (except for samples collected in room 32 a few hours after patient P7 had been transferred to an intensive care unit). Water samples were collected from different faucets (nursing room, medication preparation rooms, and rooms of some patients). First-catch lukewarm water (500 mL) was collected in sterile bottles containing 20 mg/L sodium thiosulfate and concentrated by filtration (0.45-μm membrane filters). All sinks and shower drains were sampled by rotating a cotton swab inserted through the drain. Toilets were sampled with swabs inserted under the rim of the toilet bowl.

![Environmental testing for IMP-19 producers in investigation of nosocomial infections linked to contaminated sinks, France. A) Sink (blue circles), swab specimen of sink, and drain (red circles) tested. B) Flowchart of testing procedure.](16-0649-F1){#F1}

We plated samples from filters (for water) and swab specimens (from sinks) on Drigalski medium containing ceftazidime (32 mg/L). When a positive culture was observed after 48 hours of incubation, a PCR specific for *bla*~IMP-19~ was performed for the culture mixture. For samples with a positive PCR result, we then plated a dilution of the culture mixture on Drigalski medium containing ceftazidime (32 mg/L) and imipenem (16 mg/L) to obtain isolated colonies, which we further subjected to identification and confirmation of IMP-19 production.

Many resistant organisms were detected in these environmental samples. We used mass spectrometry and *nrdA* gene sequencing to identify for *Achromobacter* isolates ([@R6]). *bla*~IMP-19~ and integrons were detected as described ([@R7]*,*[@R8]). We used pulsed-field gel electrophoresis after *Xba*I digestion to genotype *P. aeruginosa* isolates ([@R9]). Pulsotypes were compared by calculating the Dice correlation coefficient with DendroUPGMA software (<http://genomes.urv.cat/UPGMA/>).

The 7 clinical isolates belonged to 3 distinct genotypes A, B, and C ([Table](#T1){ref-type="table"}; [Figure 2](#F2){ref-type="fig"}). We detected environmental IMP-19--producing isolates belonging to 8 species of gram-negative nonfermenting bacilli: *P. aeruginosa*, *Achromobacter xylosoxidans*, *A. aegrifaciens*, *P. putida*, *Stenotrophomonas maltophilia*, *P. mendocina*, *Comamonas testosteroni*, and *Sphingomonas* sp. Of the 7 environmental isolates of *P. aeruginosa* we identified, 6 belonged to the same genotype as clinical isolates (genotype A).

###### Characteristics of bacterial isolates from patients with nosocomial infections linked to contaminated sinks, France\*

  Isolate                          Origin (date)               Site               PFGE profile   Integron
  -------------------------------- --------------------------- ------------------ -------------- ----------
  *Pseudomonas aeruginosa* PA1     Patient P1 (2009 Feb)       Urine              A              D
  *P. aeruginosa* PA2              Patient P2 (2009 Apr)       Blood              B              A
  *P. aeruginosa* PA3              Patient P3 (2009 Jun)       Throat             A              D
  *P. aeruginosa* PA4              Patient P4 (2013 Oct)       Urine              A              D
  *P. aeruginosa* PA5              Patient P5 (2015 Oct)       Central catheter   C              F
  *P. aeruginosa* PA6              Patient P6 (2015 Dec)       Throat             B              A
  *P. aeruginosa* PA7              Patient P7 (2016 Jul)       Blood              A              ND
  *P. aeruginosa* PA8              Room 10 (protective unit)   Sink               Unrelated      G
  *P. aeruginosa* PA9              Room 40                     Shower drain       A              A
  *P. aeruginosa* PA10             Room 40                     Shower drain       A              E, F
  *P. aeruginosa* PA11             Room 40                     Sink               A              B, C
  *P. aeruginosa* PA12             Room 46                     Shower drain       A              D
  *P. aeruginosa* PA13             Room 32                     Sink               A              ND
  *P. aeruginosa* PA14             Room 32                     Toilet bowl        A              ND
  *Achromobacter xylosoxidans*     Room 48                     Sink               ND             F
  *A. aegrifaciens*                Room 32                     Toilet bowl        ND             E, F
  *A. aegrifaciens*                Room 37                     Shower drain       ND             E, F
  *P. putida*                      Room 32                     Toilet bowl        ND             E, F
  *P. putida*                      Room 4                      Shower drain       ND             E, F
  *P. putida*                      Room 64                     Shower drain       ND             G
  *P. putida*                      Room 65                     Toilet bowl        ND             C
  *Sphingomonas*sp.                Room 12 (protective unit)   Sink               ND             ND
  *Comamonas testosteroni*         Room 46                     Sink               ND             ND
  *P. mendocina*                   Room 40                     Shower drain       ND             E, F
  *Stenotrophomonas maltophilia*   Room 44                     Sink               ND             ND

\*ND, not determined; PFGE, pulsed-field gel electrophoresis.

![Unweighted pair group method with arithmetic mean cluster analysis of *XbaI*-generated pulsotypes constructed with Dice coefficients for the 7 clinical isolates and the 7 environmental isolates of IMP-19−producing *Pseudomonas aeruginosa* linked to contaminated sinks, France. Isolates are indicated on dendrogram branches. The Dice coefficient scale is indicated at the bottom of the dendrogram.](16-0649-F2){#F2}

The *bla*~IMP-19~ gene was located in various integrons, mainly on a *su*l-type class 1 integron and A *Tn402*-like class 1 integron. In these integrons, *bla*~IMP-19~ was associated with different gene cassettes, including *aac(6′)-Ib*, *aadA13*, *aadB*, or fused *qacG-aac(6′)-Ib* ([Figure 3](#F3){ref-type="fig"}). Few isolates had several copies of *bla*~IMP-19~ located on integrons of different structures ([Table](#T1){ref-type="table"}).

![Diversity of integrons harboring *bla*~IMP-19~ isolated from patients with nosocomial infections linked to contaminated sinks, France. Arrows indicate direction of transcription. a--f, *suI*-type class 1 integrons; g, Tn*402*−like class 1 integron. *aac(6′)-Ib*, aminoglycoside 6′-N-acetyltransferase; *aadA13*, aminoglycoside adenyltransferase ANT(3′); *aadB*, aminoglycoside-2′′-O-nucleotidyltransferase; *bla*~IMP-19~, metallo-β-lactamase IMP-19; fused *qacG*, aminoglycoside 6′-N-acetyltransferase; *intl1*, class 1 integron integrase; *orf5*, open reading frame 5; *qacEΔ1*, multidrug exporter; *sul1,* dihydropteroate synthase; *tniQ*, transposition protein; *tniR*, resolvase.](16-0649-F3){#F3}

Conclusions
===========

The incidence of MBL producers among imipenem-resistant *P. aeruginosa* in France is low compared with incidences for other countries ([@R2]*,*[@R10]). Reports of outbreaks are scarce and usually involve VIM producers ([@R11]*,*[@R12]). Therefore, detection of IMP-19 producers in our hospital was unusual. The long intervals without cases, the absence of any overlap between cases, and genotypic diversity of clinical isolates did not suggest a single common source of infection. These findings prompted us to conduct environmental investigations.

IMP-19 producers were detected in 9 of 15 rooms in the conventional unit and 2 of 9 rooms in the protective isolation unit. These producers were *P. aeruginosa* and a wide variety of gram-negative nonfermenting bacilli. Most of these producers have little clinical relevance, but they are silent reservoirs for dissemination of *bla*~IMP-19~ to major pathogens. The role of these environmental bacterial species in the spread of MBL suggested in previous studies ([@R13]*,*[@R14]) is confirmed by our findings.

The diversity of species found and genetic structures involved with *bla*~IMP-19~ indicated that the environmental contamination occurred a long time ago. One isolate of IMP-19--producing *Aeromonas caviae* was found in a patient in the same building in 2006 ([@R7]). This phenomenon is probably endemic to our hospital, in which sink drains are not accessible for removal of biofilms without complete dismantling (inappropriate sink design).

Transfer of pathogens from sinks to patients might occur in several ways. Water from faucets is directed straight into the drain, resulting in splashing that can lead to contamination of an area [\<]{.ul}1 m from the sink ([@R15]). Therefore, patients can be contaminated when they brush their teeth, wash their hands, or take a shower. Healthcare personnel are also at risk for hand contamination, which might lead to transfer of pathogens to patients during care.

All patients had [\>]{.ul}1 stay in rooms that were positive for IMP-19--producing organisms. After patient P7 died of sepsis, all drains in the ward were changed. However, this measure did not eradicate biofilms found in the plumbing system. Because the building tested was 16 years old, it has been decided to completely rebuild the ward in early 2017, paying special attention to water distribution and discharge systems to minimize hospital-acquired infections. In conclusion, our findings might help other hospitals to identify potential reservoirs of carbapenemase-producing bacteria and lead to implementation of rapid control measures to contain outbreaks.
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